Pfizer-BioNTech COVID-19 shot cleared for adolescents in U.S. Sorry, but your browser needs Javascript to use this site. If you re not sure how to activate it, please refer to this site: https://www.enable-javascript.com/
Alejandra Gerardo, 9, looks up at her mother as she gets the first dose of the Pfizer COVID-19 vaccine during a clinical trial for children at Duke Health in Durham, North Carolina, in February. | DUKE HEALTH / VIA REUTERS
Bloomberg May 11, 2021
Pfizer Inc. and BioNTech SE’s COVID-19 vaccine has been cleared for use in younger teens in the U.S., paving the way for the mass vaccination of middle- and high-school students before the start of summer camps and the next school year.
âWe hope to help bring a sense of normalcy back to young peopleâ: Pfizer vaccine authorized for adolescents 12-15 years old
By Jonathan Saltzman and Robert Weisman Globe Staff,Updated May 10, 2021, 7:45 p.m.
Email to a Friend
The Food and Drug Administration on
Monday cleared Pfizer-BioNTechâs coronavirus vaccine for adolescents 12 to 15 years old, enabling millions of more Americans to get the two-shot regimen.
Five months after the agency authorized Pfizerâs vaccine for emergency use in people 16 and older, Acting FDA Commissioner Janet Woodcock said the expansion represented a major advance in the fight against the virus.
âTodayâs action allows for a younger population to be protected from COVID-19, bringing us closer to returning to a sense of normalcy and to ending the pandemic,â she said. âParents and guardians can rest assured that the agency undertook a rigorous and thorough review of all available data, as we have with all of our
May 11 2021, 4:55 PM
May 11 2021, 2:45 AM
May 11 2021, 4:55 PM
(Bloomberg)
(Bloomberg)
Pfizer Inc. and BioNTech SEâs Covid-19 vaccine was cleared for use in younger teens in the U.S., paving the way for the mass vaccination of middle- and high-school students before the start of summer camps and the next school year.
The Food and Drug Administration said in a statement Monday that it had expanded the shotâs original emergency use authorization to include adolescents 12 to 15 years of age.
âIt was a relatively straightforward decision,â said Peter Marks, director of the FDAâs Center for Biologics Evaluation and Research, at a news conference. The vaccine generated a strong immune response, there were no cases of Covid in the vaccinated group, and there were no signs of any new or worrisome side effects, he said.
AP Story talkradio1170.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from talkradio1170.com Daily Mail and Mail on Sunday newspapers.
AP Story talkradio1170.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from talkradio1170.com Daily Mail and Mail on Sunday newspapers.